Ubicom Holdings. Inc. · TSE:3937
Ubicom — Q3 2021 Earnings Presentation
22 slides from Ubicom's earnings presentation, Feb 10, 2022
Slide 1: Presentation Materials for FY2021 Q3
FY2021 Q3 Consolidated Business Results Presentation Materials for FY2021 Q3 Ubicom Holdings, Inc. TSE First Section: Feb. 10, 2022 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the
Slide 2: FY2021 Q3 Highlights
FY2021 Q3 Highlights The established high-profit model turned out to be effective, and the strategic investment we conducted in the first half increased sales and profit. Profit hit a record high for the third quarter. Net Sales 3,452 million yen Ordinary Income 714 million yen （111.1％ year-on-year)
Slide 3: FY2021 Q3 (P/L)
FY2021 Q3 (P/L) In order to meet the strong demand for development and solutions expected in the future, we enhanced strategic investment in leading-edge human resources. Ordinary income increased by about 15% year on year. FY2020 FY2021 3 rd quarter 3 rd quarter Year-on- % to % to Year [unit: milli
Slide 4: Overview of FY2021 3Q Group's Strategic Investment, etc.
Overview of FY2021 3Q Group’s Strategic Investment, etc. We boldly conducted investment for developing new pillar clients from whom an order amount of 100 million yen or larger is expected in the next term, and investment in education for medical engineers. ■3Q Strategic Investment: Approximately 30
Slide 5: FY2021 Q3 Segment Overview: Global Business
FY2021 Q3 Segment Overview: Global Business We conducted strategic investment in human resources spending about 25 million yen ahead of schedule for accelerating the increase of customers, but secured an increase in profits from the previous fiscal year. FY2020 FY2021 Global Business Year-on- 3 quar
Slide 6: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment of Offshore (our d
Slide 7: Global Business: Efforts and Progress Toward Mid-term Vision
Global Business: Efforts and Progress Toward Mid-term Vision Promote acquisition of potential pillar clients and expand opportunities per customer ■FY2021 1～3Q Results: acquired 11 new potential pillar clients 3Q In addition to acquiring new customers (real estate tech, automation companies), we foc
Slide 8: Global Business: Themes for Mid- to Long-Term
Global Business: Themes for Mid- to Long-Term Promote business strategies targeted at the global market ■ Visions for the Global Business ① Offshore x bilingual (Japanese and English) x DX human resources (545,000 engineers short in 2030*) ② Provision of attractive career opportunities for young per
Slide 9: FY2021 3Q Segment Overview: Medical Business
FY2021 3Q Segment Overview: Medical Business FY2020 FY2021 Medical Business 3 rd quarter 3 rd quarter Year-on- Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 1,042 100.0% 1,115 100.0% 107.0% Operating Income 528 50.6% 627 56.2% 118.8% • In the 3Q of FY2021, operating income g
Slide 10: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance Sales Composition Trend of Medical Business (unit: million yen) *recurring ratio: continuous sales ratio © Ubicom Holdings, Inc. 10
Slide 11: Medical Business: Effects of Mainstay Solutions
Medical Business: Effects of Mainstay Solutions ■Effects of Mighty Checker (MC) for Medical Affairs *1 (1) Reduction of operation time (2) Cost reduction and profit improvement Conventional medical claims inspection Inspection (Visual) of medical claims after introducing MC Inspection cost 100% Redu
Slide 12: Insurance Knowledge Platform: Progress 1
Insurance Knowledge Platform: Progress 1 Commencement of use of the DX feature, Fluctuation Correction for partial automation of insurance payment operations From medical documents that have been converted to text by OCR... Classification Item Name Surgery Extraction of parotid gland tumor (deep lob
Slide 13: Insurance Knowledge Platform: Progress 2
Insurance Knowledge Platform: Progress 2 ■Progress of opportunities under negotiation ・Negotiations are underway with a total of 7 out of approx. 50 companies in the life insurance market ➡out of which, 3 companies are in the process of PoC verification for installation in FY2022 ➡2 semi-major compa
Slide 14: Medical Domain: Growth Potential of each Solution
Medical Domain: Growth Potential of each Solution To promote further improvement of average spending per customer and recurring revenue earning capability through up-selling, cross-selling, and direct sales New Medical Platform Insurance Knowledge Platform SonaM Mighty Checker EX GP margin of Mighty
Slide 15: Target Market Size for Medical Platforms
Target Market Size for Medical Platforms We aim to become the No. 1 platform in the niche medical field by leveraging our position as the market leader in DX solutions focused on medical institutions. New (domestic and overseas) Insurance Strategic Medical companies Markets institutions Insurance Kn
Slide 16: Medical Platform Utilization Strategy (Medium/Long-term Vision)
Medical Platform Utilization Strategy (Medium/Long-term Vision) To create more new markets through strategies to enclose the user community (potential market size: 300 billion yen*) *surveyed by our company ・Conversion of sales staff to consultants New market ・Medical engineer training Creation ・Str
Slide 17: Consideration of M&A in the Medical Field
Consideration of M&A in the Medical Field Promotion of overseas M&A in the medical infrastructure field We began preparations for exclusive negotiations with overseas company that has core competence in the medical field, which is our strategic domain. We will proceed with the formulation of a g
Slide 18: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・Client DX (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/cloud) ・New Normal promotion (Offshore leveraging, non-face-to-face/non-contact/remote solution d
Slide 19: Promotion of the Leverage Strategy (the 2nd Growth Phase)
Promotion of the Leverage Strategy (the 2 nd Growth Phase) To maximize the synergy between the existing business and M&A, and promote the development of new recurring-revenue/SaaS model ・Medical field Themes of the ・Pillar clients: + 20 companies ・Global market second growth phase ・Sustainability No
Slide 20: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE First Section: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business is dedicated in solving IT resource shortage and promoting DX (Digital Transformation) in Japan, thr
Slide 21: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 22: © Ubicom Holdings, Inc.
© Ubicom Holdings, Inc.